An analysis of data from a cohort of patients with ENKTL from the T-cell Project (NCT01142674), exploring the clinical characteristics and...
Update on CLL induction therapy
An interview with Astrid Pavlovsky, Fundaleu CHP, Buenos Aires, AR, on the first-line treatment of chronic lymphocytic leukemia (CLL).
Brentuximab vedotin receives positive CHMP opinion in combination with CHP as treatment for adult patients with previously untreated sALCL
On March 31, 2020, the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP)...
Nivolumab treatment followed by consolidation with allo-HSCT is associated with favorable outcomes in patients with relapsed/refractory Hodgkin lymphoma
Nivolumab is an immune checkpoint inhibitor approved for the treatment of classical Hodgkin...
"The Lymphoma Hub allows you to navigate the most relevant and up-to-date information in lymphoma and CLL. From recently published papers to on-site interviews, we aim to deliver valuable data to all physicians practicing hemato-oncology."